Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2018
Pharma News, 2018
Celgene to buy Impact Biomedicines for up to $7 billion
U.
Lupin launches generic Ancobon
Lupin has added to its generics lineup with its version of Valeant Pharmaceuticals’ Ancobon (flucytosine) capsules.
Takeda to acquire TiGenix in $630 million deal
Japan’s largest drugmaker Takeda Pharmaceutical (TYO.
Leading Pharma gets $40 million infusion for growth
Generic maker Leading Pharma recently completed a financing transaction for $40 million of growth capital.
Alnylam and Sanofi Enter into Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance
CAMBRIDGE, Mass.
Atlas Venture Launches Generation Bio
Cambridge, Mass.
ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration
SAN DIEGO and BONN, Jan.
Pfizer ends research for new Alzheimer's, Parkinson's drugs
NEW YORK (Reuters) - Pfizer Inc (PFE.
67
68
69
70
71
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds
